CD8A and neoplasm: To identify the anti-tumor immune cellular mechanism of NPRL2, we evaluated the antitumor effect of NPRL2 on LLC2 syngeneic tumors after depleting cytotoxic CD8+ T, CD4+ T, NK, and antigen-presenting macrophages and dendritic cells in mice.